Industry heavyweight Compass Pathways launched the current rally in psychedelic stocks. But four other stocks have been outperforming CMPS.
MindMed Cashes In, $25 Million Bought Deal Financing
MindMed has capitalized on its recent market success to raise new capital on more favorable terms.
MindMed Announces $25 Million Bought Deal Public Offering
MindMed announces a CAD$25 million bought-deal financing at CAD$1.05 per unit.
Field Trip Adds Acclaimed Physician, Dr. Andrew Weil, to Medical Advisory Board
Field Trip has appointed a leader in holistic and integrative medicine to its Medical Advisory Board.
Mind Cure Assembles Cast For Psychedelic Drug Success
After a series of significant corporate appointments, Mind Cure is poised to advance its operations.
Numinus Commences Psilocybe Mushroom Cultivation
Numinus commences psilocybin cultivation as part of its "ecosystem approach" to psychedelic drug therapy.
Release: Health and Wellness Industry Tastemaker Jon Bier Joins Mind Cure's (CSE: MCUR) Advisory Board
Mr. Bier is a communications and strategy expert who has played a key role in building brands such as Four Sigmatic and WHOOP
Prominent Psychedelic Medicine Researcher Added To Mind Cure Team
This is Mind Cure's third high-profile addition to its Scientific Advisory Board in the last week.
Mind Cure Welcomes Dr. Jason Wallach to Scientific Advisory Board
Mind Cure's latest addition to its Scientific Advisory Board is a noted expert in psychedelic medicine, published researcher, and professor of pharmacology.
Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin
Mydecine's new patent application may lead to a way to derive the medicinal benefits of psilocybin at lower doses.
Mind Cure Adds 'Hamilton's Pharmacopiea' Creator As Scientific Advisor
Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.
Mind Cure Welcomes Award-Winning Journalist and Science Researcher Hamilton Morris to Advisory Board
Noted psychedelic drug expert, Hamilton Morris, is the latest addition to Mind Cure's advisory board.
